Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:45 AM
Ignite Modification Date:
2025-12-25 @ 1:45 AM
NCT ID:
NCT00760994
Eligibility Criteria:
Inclusion Criteria:
* age at least 18 years
* current DSM-IV diagnosis of alcohol dependence (AD) with some alcohol use in the last month
* current DSM-IV diagnosis of post-traumatic stress disorder (PTSD)
* capacity to provide informed consent
* English fluency
* no planned absences that they would be unable to complete 6 weeks of daily monitoring and study sessions
* access to a telephone
* desire to decrease or stop alcohol drinking behavior
Exclusion Criteria:
* a history of delirium tremens
* seizures, in order to ensure that participants will be medically safe to decrease alcohol use
* opiate abuse or dependence use or chronic treatment with any opioid- containing medications during the previous month
* currently taking or planning to start taking either antabuse or naltrexone (due to their pharmacological impact on alcohol cravings and use)
* exhibits signs or symptoms of alcohol withdrawal at the time of initial consent
* acutely suicidal with intent/plan or present an imminent danger to others
* a current psychotic disorder
For ethical reasons and because of the preliminary nature of this study, participants may be in ongoing substance abuse or mental health treatment (MH) or may initiate counseling or medications (other than those noted in exclusion criteria) during the course of the study. Mental health treatment involvement will be used as a covariate if it is related to study dependent variables.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00760994
Study Brief:
Protocol Section:
NCT00760994